CARLSMED, Inc. Reports Preliminary 2025 Revenue

What Happened
CARLSMED, Inc. announced preliminary and unaudited revenue for the fiscal year ended December 31, 2025 in a press release issued January 12, 2026. The company furnished the press release as Exhibit 99.1 to its Form 8-K filed the same day. The Form 8-K was signed by CEO Michael Cordonnier.

Key Details

• Filing date: January 12, 2026 (Form 8-K, Item 2.02).
• Subject: Preliminary, unaudited revenue for the year ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the 8-K (full text included in the filing).
• CEO Michael Cordonnier signed the filing; an Inline XBRL cover page (Exhibit 104) was also included.

Why It Matters
Revenue for the full year is a primary measure of company performance and can affect investor valuations and short-term market reaction. Because the figures are described as preliminary and unaudited, they may be adjusted in subsequent filings (such as the annual report/10-K). Retail investors should review the attached press release for the reported amounts and monitor the company’s forthcoming audited filings for confirmation and additional context.